Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMZAR for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where GEMZAR was used for Bladder cancer.

Most Reported Side Effects for GEMZAR

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 15 11.3% 6 9
Anaemia 14 10.5% 5 7
Off label use 13 9.8% 2 10
Pleural effusion 13 9.8% 0 8
Pyrexia 13 9.8% 2 9
Interstitial lung disease 12 9.0% 9 9
Decreased appetite 10 7.5% 5 9
Diarrhoea 10 7.5% 2 6
Renal failure acute 10 7.5% 3 9
Lung disorder 9 6.8% 2 4
Thrombocytopenia 9 6.8% 5 5
Vomiting 8 6.0% 2 4
Dyspnoea 7 5.3% 1 4
Metastases to bone 7 5.3% 1 0
Metastases to liver 7 5.3% 2 0

Other Indications for GEMZAR

Pancreatic carcinoma (18) Breast cancer (13) Product used for unknown indication (10) Lung neoplasm malignant (9) Cholangiocarcinoma (5) T-cell lymphoma (5)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

GEMZAR Full Profile All Bladder cancer Drugs GEMZAR Demographics GEMZAR Timeline